PVCT
PROVECTUS BIOPHARMS
stockOTC
EODOct 2, 2026
0.0544USD0.000%(0.00)15,072
Loading…
Loading…
22.84M
Healthcare
Biotechnology
HQ
Knoxville, TN, USA
Previous Close
$0.05
Beta
0.12
52-Week High
$0.08 2025-10-06
52-Week Low
$0.04 2026-02-06
SMA 50
$0.06
SMA 200
$0.06
Avg. Vol 10D
92,910
Avg. Vol 30D
139,883
Avg. Vol 90D
153,133
Relative Vol
0.11
419.91M
387.87M
801,174
0.21%
4.56
74.20%
4,423
4,423
4,423
Apr 11, 2002 · 1-for-300.3003 (reverse)
PVCT Profile
provectus biopharmaceuticals is investigating new therapies for the treatment of skin cancer, liver cancer and breast cancer. provectus' investigational oncology drug, pv-10, is an ablative immunotherapy under investigation in solid tumor cancers.
PVCT Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 0.06 | 2026-09-28 | -4.89% | -0.279 |
| 1M | 0.06 | 2026-09-04 | -9.33% | 1.091 |
| 3M | 0.07 | 2026-07-06 | -20.93% | -0.437 |
| 6M | 0.05 | 2026-04-06 | +9.46% | -0.624 |
| 1Y | 0.08 | 2025-10-06 | -35.89% | 0.118 |
| 2Y | 0.11 | 2024-10-04 | -50.55% | — |
| 5Y | 0.06 | 2021-10-05 | -16.18% | -0.026 |
PVCT Stock Summary
PROVECTUS BIOPHARMS (OTC:PVCT) stock price today is $0.05, and today's volume is 15,072. PVCT is up 0.000% today. The 30 day average volume is 139,883. PVCT market cap is $22.84M with 419.91M shares outstanding.